Knudsen KE - Search Results

1

Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity.

Petre CE, Wetherill YB, Danielsen M, Knudsen KE. Petre CE, et al. Among authors: knudsen ke. J Biol Chem. 2002 Jan 18;277(3):2207-15. doi: 10.1074/jbc.M106399200. Epub 2001 Nov 19. J Biol Chem. 2002. PMID: 11714699 Free article.

2

The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells.

Wetherill YB, Petre CE, Monk KR, Puga A, Knudsen KE. Wetherill YB, et al. Among authors: knudsen ke. Mol Cancer Ther. 2002 May;1(7):515-24. Mol Cancer Ther. 2002. PMID: 12479269

3

Specificity of cyclin D1 for androgen receptor regulation.

Petre-Draviam CE, Cook SL, Burd CJ, Marshall TW, Wetherill YB, Knudsen KE. Petre-Draviam CE, et al. Among authors: knudsen ke. Cancer Res. 2003 Aug 15;63(16):4903-13. Cancer Res. 2003. PMID: 12941814

4

Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.

Burd CJ, Petre CE, Morey LM, Wang Y, Revelo MP, Haiman CA, Lu S, Fenoglio-Preiser CM, Li J, Knudsen ES, Wong J, Knudsen KE. Burd CJ, et al. Among authors: knudsen ke, knudsen es. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2190-5. doi: 10.1073/pnas.0506281103. Epub 2006 Feb 6. Proc Natl Acad Sci U S A. 2006. PMID: 16461912 Free PMC article.

5

Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression.

Burd CJ, Petre CE, Moghadam H, Wilson EM, Knudsen KE. Burd CJ, et al. Among authors: knudsen ke. Mol Endocrinol. 2005 Mar;19(3):607-20. doi: 10.1210/me.2004-0266. Epub 2004 Nov 11. Mol Endocrinol. 2005. PMID: 15539430

6

Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status.

Wetherill YB, Fisher NL, Staubach A, Danielsen M, de Vere White RW, Knudsen KE. Wetherill YB, et al. Among authors: knudsen ke. Cancer Res. 2005 Jan 1;65(1):54-65. Cancer Res. 2005. PMID: 15665279

7

Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer.

Wetherill YB, Hess-Wilson JK, Comstock CE, Shah SA, Buncher CR, Sallans L, Limbach PA, Schwemberger S, Babcock GF, Knudsen KE. Wetherill YB, et al. Among authors: knudsen ke. Mol Cancer Ther. 2006 Dec;5(12):3181-90. doi: 10.1158/1535-7163.MCT-06-0272. Mol Cancer Ther. 2006. PMID: 17172422

8

Differential requirement of SWI/SNF for androgen receptor activity.

Marshall TW, Link KA, Petre-Draviam CE, Knudsen KE. Marshall TW, et al. Among authors: knudsen ke. J Biol Chem. 2003 Aug 15;278(33):30605-13. doi: 10.1074/jbc.M304582200. Epub 2003 May 29. J Biol Chem. 2003. PMID: 12775722 Free article.

9

Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function.

Comstock CES, Augello MA, Schiewer MJ, Karch J, Burd CJ, Ertel A, Knudsen ES, Jessen WJ, Aronow BJ, Knudsen KE. Comstock CES, et al. Among authors: knudsen ke, knudsen es. J Biol Chem. 2011 Mar 11;286(10):8117-8127. doi: 10.1074/jbc.M110.170720. Epub 2011 Jan 5. J Biol Chem. 2011. PMID: 21212260 Free PMC article.

10

Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest.

Knudsen KE, Fribourg AF, Strobeck MW, Blanchard JM, Knudsen ES. Knudsen KE, et al. Among authors: knudsen es. J Biol Chem. 1999 Sep 24;274(39):27632-41. doi: 10.1074/jbc.274.39.27632. J Biol Chem. 1999. PMID: 10488103 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters